Helath News from Lupus Foundation.

FDA Approves New Treatment for Lupus

On March 9, 2011, BENLYSTA® was approved by the FDA as the first treatment approved for lupus in more than 50 years, and more importantly, the first drug ever to be specifically designed to treat the disease. Here are some resources to help you learn more about what this news means:
Learn answers to Frequently Asked Questions about BENLYSTA

Learn from lupus experts as they discuss the advances in new treatments for lupus in a webcast. Sign up to be notified of the date when it’s announced.

BENLYSTA Gateway is a centralized resource for patients and health care providers for one-on-one services and support.  For more information, please call 1-877-4-BENLYSTA, Monday through Friday, 8AM to 8PM (EST). You can also visit www.benlysta.com for more information.
Read stories about what this advance in lupus treatment means to people living with lupus.

In order to develop a full arsenal of tolerable and effective treatments to help improve your quality of life of those living with lupus, ongoing clinical trials are necessary. We encourage you to learn more about clinical trials at the LFA’s Center for Clinical Trials Education. While you’re there, you can sign up for the Lupus Research Registry to learn more about lupus clinical trials in your area.